View Full Text | Abstract |
Article as PDF | Print this Article |
Pubmed | PMC |
PubReader | Export to Citation |
Email Alerts | Open Access |
Exp Neurobiol 2013; 22(4): 337-340
Published online December 30, 2013
https://doi.org/10.5607/en.2013.22.4.337
© The Korean Society for Brain and Neural Sciences
Jung-Ju Lee1, Soon-Tae Lee2, Keun-Hwa Jung2, Kon Chu2 and Sang Kun Lee2*
1Department of Neurology, Eulji General Hospital, Eulji University College of Medicine, Seoul 139-872, 2Department of Neurology, Comprehensive Epilepsy Center, Biomedical Research Institute, Seoul National University Hospital, Seoul 110-744, Korea
Correspondence to: *To whom correspondence should be addressed.
TEL: 82-2-2072-2923, FAX: 82-2-2072-7424
e-mail: sangkun2923@gmail.com
Anti-leucine-rich glioma inactivated-1 (LGI1) limbic encephalitis (LE) is a rare neurological disorder that has a subacute course of progressive encephalopathy and fasciobrachial dystonic seizures. We report a patient with anti-LGI1 LE that presented with atypical manifestations that complicated the diagnosis. A 62-year-old woman presented with a chronic course of memory disturbance and a subsequent relapse with an altered mental status after 10 months. The patient reported frequent chest pain of squeezing and dull nature, typically lasting 10-30 seconds. The chest pain was related to partial seizures, which were confirmed by video-EEG monitoring. Anti-LGI1 antibody was identified in serum and CSF. The patient's symptoms improved by immune modulation treatment. Patients with anti-LGI1 LE can experience atypical partial seizures, and a chronic relapsing course. Clinical suspicions and video-EEG monitoring are helpful for the early diagnosis and effective immune modulation.
Keywords: limbic encephalitis, chest pain, seizure, immune